Background The US National Institutes of Mental Health Research Domain Criteria (RDoC) seek to stimulate research into biologically validated neuropsychological dimensions across mental illness symptoms and diagnoses. The RDoC framework comprises 39 functional constructs designed to be revised and refined, with the overall goal of improving diagnostic validity and treatments. This study aimed to reach a consensus among experts in the addiction field on the 'primary' RDoC constructs most relevant to substance and behavioural addictions.
INTRODUCTION
The aetiopathogeny of addiction remains poorly understood, as we lack assessment models to identify vulnerability to addiction. Only 10-20% of patients with substance and behavioural addictions receive treatment [1] [2] [3] , which tend to have modest outcomes, reflected in low compliance and high relapse rates [4] . Thus, there is an urgent need for alternative assessment and intervention strategies to prevent or reduce the personal, social and economic burden associated with addictions.
Important developments in neuroscience have begun to reshape how addictions are understood [5] [6] [7] . For instance, many individuals with addictions exhibit neuropsychological deficits across a range of functions subserved by reward, stress and cognitive-control brain circuitries [8] . These neuropsychological dysfunctions transcend traditional diagnostic boundaries and form a shared pathophysiological mechanism core to substance and behavioural addictions [9] [10] [11] . Rapidly emerging evidence affirms that such mechanisms and processes result from dysfunction in frontal-subcortical brain circuits [12, 13] .
Key dysfunctions commonly shared across addictions include aberrant reward-processing (e.g. inability to delay gratification; reward prediction error-the erroneous prediction of potential gains and losses associated with addictive behaviours) and increased stress sensitivity (e.g. elevated baseline stress levels; stress-related cravings). These constructs may underlie reduced sensitivity to the negative consequences of addiction-related actions (e.g. drug misuse or excessive betting) and have been associated with the development and later relapse of addictive behaviours [12, [14] [15] [16] [17] [18] [19] [20] [21] . Other shared dysfunctions include impaired self-control (e.g. reduced top-down, inhibitory control); linked to dysfunction in frontal-subcortical brain circuits ascribed to decision-making and goal-directed behaviour [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] which limit recovery [32] [33] [34] [35] [36] . While there may not be a single phenotype, or set of related neural processes, that confers vulnerability to addictions, impairment in these reward, stress and control-related processes may shape various pathways in and out of the addiction cycle.
Considering the above, superficially disparate (but conceptually related) disorders, such as substance-use and gambling disorders, may be underpinned by overlapping neuropsychological processes and neural circuits. Such disorders may respond to similar interventions that target these common underlying mechanisms, such as naltrexone (an opioid-receptor antagonist), which is effective in treating alcohol use disorder and gambling disorders putatively by targeting overlapping dysfunctional neurobiological systems [37] [38] [39] . Synthesizing findings on effective treatments common to different substance and behavioural addictions would clarify shared mechanisms across addictive behaviours. It will also help to adjudicate whether a transdiagnostic approach is most appropriate, given alternative conceptualizations with the impulse control disorders and a putative compulsivity spectrum [40, 41] . Importantly, the transdiagnostic approach highlights the clinical utility of targeting neuropsychological systems linked to disturbances in reward processing, stress reactivity and self-control.
Nevertheless, with the exception of some developments such as cognitive-bias modification [42] , current approaches to clinical assessment and management have largely failed to integrate these developments into assessment and intervention tools. Two principal barriers to translation remain: (i) psychiatric assessment and diagnostic tools are based largely on characterization of symptoms (versus mechanisms), predicated on clinical reliability rather than biological validity, and based on self-reports and observable behaviours rather than empirically measured dimensions; and (ii) neuropsychological assessments (as applied in the clinic) are based typically on paradigms developed decades ago for use in brain lesion cases and neurological disorders, which may lack sensitivity to the specific cognitive-emotional constructs key to the psychopathology of addiction.
To help address these shortcomings, the US National Institute of Mental Health (NIMH) developed the Research Domain Criteria (RDoC) initiative as a tool to encourage researchers to '…develop, for research purposes, new ways of classifying mental disorders' beyond traditional nosologies, which were based on describing and counting overt signs and symptoms and arbitrary clinical thresholds and boundaries that encompass diverse and overlapping biological mechanisms [43] . Biobehavioural dimensions captured by RDoC are measurable and linked to neural circuits and psychopathology; these are laid out as a series of matrices. Each matrix represents a functional domain that comprises several cognitive and affective processes, divided systematically into smaller subunits, each reflecting a specific measure of their corresponding construct. Contrary to the diagnostic classification system [44] , the goal of this model is to use a data-driven approach to determine constructs that aid in the understanding and classification of mental disorders. These classifiers are intended to serve as 'intermediate phenotypes', or neuroscientifically derived measures for improved biological modelling and targeted treatment interventions [45, 46] .
The RDoC framework offers a neuroscientifically grounded approach to bridge clinical practice with neuroscience. It is operationalized via the RDoC matrix, which is designed to promote ongoing testing and refinement. 1 With regard to addiction, several constructs in the RDoC matrix could be used to conceptualize transdiagnostic processes implicated in such disorders. However, there is currently a lack of consensus on the discrete processes of the addiction cycle (i.e. initiation, regular use, impaired control, cessation, relapse) [47] [48] [49] [50] , probably reflecting the different processes and phenotypes that interact at different stages of addictions and/or a lack of evidence-based conclusions. For instance, the Positive Valence System is related to the early stages of addictive disorders, where drug use (for example) may lead to positive experiences (such as increased social bonding). Instead, the Negative Valence 1 System might potentially be more relevant for avoidance of negative experiences (withdrawal symptoms) once drugseeking has become habitual and compulsive; the so-called 'end-state' of substance-use disorders [51] .
A common approach in mental health research to developing and refining research criteria, guidelines, reporting standards and protocols is the Delphi method [52] . It is often used to capture practice-based evidence, through an iterative process whereby a panel of topic experts is repeatedly surveyed until a consensus is reached among them (which may be 'agreeing to agree' or 'agreeing to disagree'). In this study, we applied the Delphi method to synthesize expert opinion on which RDoC constructs and associated paradigms are most relevant to current understanding of addiction. The overarching aim of this large, international consensus study is to strengthen and integrate the knowledge gained from addiction neuroscience with clinical practice. A first step towards this goal is to develop a core assessment and classification protocol for substance and behavioural addictions through probing shared, key neuropsychological constructs, with the potential to improve health outcomes by allowing individuals to have their treatments tailored according to their underlying phenotype.
METHODS

Expert panel
Recruited through purposive sampling, expert selection was based on being known to the research group (M.Y., A.C., L.F., A.V.G.), having relevant clinical and/or research experience or being internationally renowned experts in substance and/or behavioural addictions. A minimum of 5 years of professional experience and more than 50 scientific articles authored in peer-reviewed journals were additional requirements. Using the procedure outlined by Okoli & Pawlowski [53] , a work-sheet was populated with potential experts who were subsequently categorized (i.e. field of expertise, profession, extent of clinical practice experience, number of publications, country and organizations), ranked and prioritized on the basis of both field of expertise and seniority in their area of expertise, and then sent invitations based on the target sample size. Although a sample of 20 has been deemed sufficient in the literature [54] , 44 experts consented and 37 participated in the study. Expert views were surveyed online over three rounds (97% completion rate), with each successive round offering feedback for experts to revaluate their opinions. These experts were recruited from Australia (n = 8), Asia (n = 1), Europe (n = 18), North America (n = 9) and South America (n = 1). The study was approved by the local (Monash University) Human Research and Ethics Committee (CF15/3407-2 015 001 454).
Procedure
Experts were required to participate in an online forum and rate the relevance of all 39 constructs of the RDoC to the concept of addiction (see Fig. 1 ). Although traditional Figure 1 Overview of the Research Domain Criteria (RDoC) schema highlighting the five major domains, comprising 23 main constructs (bold text), wherein seven of these main constructs are further broken down into 23 subconstructs (italicized text), leading to a total of 39 primary and subconstructs. Note that in June 2018 (after the immediate completion of this paper), the Positive Valence domain of the RDoC matrix underwent a reorganization. The original constructs used in this study are mostly retained, but have been reorganized somewhat differently (see https://www. nimh.nih.gov/about/advisory-boards-and-groups/namhc/reports/rdoc-changes-to-the-matrix-cmat-workgroup-update-proposed-positive-valencedomain-revisions.shtml) Delphi studies commence with an open-ended questionnaire, given the framework-driven nature of our primary aim, the RDoC constructs formed the basis of the firstround survey. To provide an opportunity for open-ended responding and to generate a more complete item pool, experts were invited to suggest any additional constructs important in understanding addiction not delineated in the RDoC. After each round, constructs that did not achieve consensus moved into the subsequent round for re-rating. These constructs were presented along with feedback outlining each expert's own previous response (blinded to other experts), the groups' previous responses (percentages reflecting range and frequency) and a synopsis of all comments offered, regardless of whether the overall view was highly consistent or divergent. Provision of these comments afforded insight and rationale leading to a more accurate consensus, as opinion change is unlikely to occur without strong causal reasoning [55] . To preserve an acceptable response rate of at least 70% across rounds [56] , and to maintain rigour, identifiable data were disclosed to key researchers to follow-up with nonresponders (up to three times each round). In the third and final round, experts who remained outside the consensus range were required to explain their rating in order to clarify their judgements [57] .
DATA ANALYSIS
Consensus and conclusion
A five-point Likert scale ranging from 1 (unimportant) to 5 (essential) was used, with a non-neutral midpoint of 3 (moderately important). Omitting a neutral mid-point forces experts to deliberate and form an opinion, and where experts did not have the knowledge, a 'don't know/unsure' option was available as an addendum [58] . Consensus was defined as ≥ 80% of experts endorsing a construct within two scale points [59] [60] [61] . Constructs were excluded from the study if consensus fell between the lowest three scale points ('unimportant' to 'moderately important') and included as 'primary constructs' if consensus was achieved between the top two scale points ('very important' to 'essential').
The criterion for concluding the Delphi was not solely contingent upon reaching consensus, but also on the stability of responses [62, 63] , allowing for any well-defined disagreement to be maintained. The process was therefore deemed complete either when all items had achieved consensus or movement between rounds was less than 15%, indicating that opinions were not likely to change further [64] .
Quantitative analyses
SPSS (version 22) (IBM Corporation, Armonk, NY, USA, 2013) was used for all quantitative analyses. For the small percentage of missing data (2.7%), pairwise deletion was applied [65] . Frequencies were calculated to assess consensus. Stability over rounds was assessed by the percentage of change [64] between rounds.
Qualitative analyses
Experts' comments underwent several stages of thematic analysis by the core committee (M.Y., A.C., L.F., A.V.G. and E.O., collectively), in order to process the data systematically, first by identifying categories and then by identifying common themes [66] . Experts were asked to rate constructs in relation to key stages of addiction in general, namely 'vulnerability' (both proximal and distal predisposing factors leading to the development of addictive disorders) and 'chronicity' (the persisting and relapsing state of addiction). Specifically, comments were first coded as being either importance-related and/or staging-related and then, within these categories, comments were coded further based on their specificity; that is, rating (unimportant to essential), and/or staging (vulnerability, chronicity). The resulting matrix was then grouped into themes. Within these themes, comments were summated and reduced to eliminate repetition, with more informative, rational or well-explained comments chosen, while retaining as much of the experts' original wording as possible [67] . As repetition of statements can increase same-thinking and result in increased confidence in one's own opinion, all types of responses were included in order to challenge conventional thinking [55] .
As suggested by Jorm [52] , the additional constructs recommended by experts were evaluated by the research team (M.Y., A.C., L.F. and A.V.G.) to confirm they were: (i) not already covered by the survey (i.e. RDoC); (ii) within the scope of the study; and (iii) articulated clearly; where they were not, the research group reviewed and adjusted the description accordingly. These additional constructs were then added to subsequent rounds.
RESULTS
Retention and characteristics of experts
Of the original 44 consenters, 37 experts completed round 1 of the Delphi questionnaires. Retention was very high, with 36 (97.3%) round 1 completers also completing both second-and third-round surveys.
Experts who completed round 1 were aged 32-67 years [mean = 43.2, standard deviation (SD) = 8.95], with 67.5% (n = 25) being male. They represented a range of professions and academic disciplines (some multiple) including scientist/neuroscientists (54.1%; n = 20), psychiatrists (27.0%; n = 10), psychologists/clinical psychologists/neuropsychologists (34.3%; n = 13), other medical doctors (5.4%; n = 2) and pharmacologists (5.4%; n = 2). Their professional settings were primarily universities (81.1%; n = 30), hospitals (21.6%; n = 8) and out-patient clinics (16.2%; n = 6), and the most commonly held academic titles were Professor (43.2%; n = 16), Associate Professor (21.6%; n = 8) and Research Fellow/Assistant Professor (24.3%; n = 9), with 89% (n = 33) of experts holding a PhD. Experts represented many areas of addiction (e.g. alcohol, cannabis opioids, gambling, internet), which supports our transdiagnostic approach.
Expert consensus on functional domains
The consensus supported the inclusion of seven primary constructs, namely: (1) reward valuation; (2) expectancy/ reward prediction error; (3) action selection/preferencebased decision-making; (4) reward learning; (5) habit; (6) response selection/inhibition; and (7) compulsivity (see Fig. 2 for flow-chart; Fig. 3 for an overview of the consensus level and range across the rounds for all constructs considered; and Table 1 for definitions). Table 1 summarizes the experts' input on the neural circuits, physiological underpinnings and behavioural correlates of the primary constructs. Although this information was not analysed quantitatively, it provides a conceptual matrix consistent with the RDoC framework.
Relevance of primary constructs to stage of disorder
As shown in Fig. 4 , 'reward valuation' was considered the most relevant to vulnerability to addictions (consensus rating of 94.6%). In contrast, while all seven primary constructs were considered to be relevant drivers of chronicity, 'habit' and 'compulsivity' were seen to be selectively relevant to chronicity and least relevant to 'vulnerability' (habit: 14.7% vulnerability, 97.1% chronicity; compulsivity: 28.5% vulnerability, 86.1% chronicity).
DISCUSSION
Utilizing Delphi methodology, experts identified a circumscribed set of RDoC constructs, as well as other novel dimensions central to understanding substance and behavioural addictions. In total, seven constructs reached consensus as being primary constructs in understanding addiction, including RDoC reward valuation, expectancy/ reward prediction error, action selection/preference-based decision-making, reward learning, habit and response selection/inhibition. Compulsivity is not described in the RDoC (at least as a monodimensional construct) but was introduced by experts. Considerable evidence exists supporting compulsivity as a core feature of addiction (although see [68] ), representing an ongoing and repeated difficulty in refraining from drug-seeking or -taking despite negative consequences. It is worth noting that the Positive Valence domain of the RDoC matrix recently underwent a reorganization (published online 28 June 2018), where both habit and aspects of compulsivity ('reward valuation') have been expanded upon, which should help in their incorporation when studying addictions. The high degree of consensus among experts across seven core constructs supports the proposition that there exists a group of common neuropsychological functions (and underlying neural processes) predisposing or maintaining addictive behaviours in individuals. These substrates primarily belong to the Positive Valence System in the RDoC matrix, which is noteworthy, as most neuropsychological assessment tools do not probe these functions thoroughly, focusing more upon cognitive skills (i.e. attention, memory, cognitive control and working memory). Much of the Positive Valence System research relies on neuroimaging methods and animal studies [69] , highlighting the need for developing better, corresponding human behavioural measures. However, the findings align with empirically grounded neuropsychological models of addictive behaviours, including: (i) the incentive sensitization theory, emphasizing the link between aberrant reward learning and alterations in reward valuation [70] ; (ii) the Impaired Response Inhibition and Salience Attribution (I-RISA) model, positing an imbalance between increased Figure 3 An overview of the consensus level and range for all 39 Research Domain Criteria (RDoC) (sub)constructs and seven additional constructs suggested by the experts for inclusion. All constructs were investigated over three rounds (only the first two rounds are shown, as the seven essential domains were derived in these rounds-all items in round three were excluded; percentages calculated relative to the total number reported). Note that expert-suggested constructs were included in round 2 (bottom seven items in the list of constructs); the red highlight indicates the constructs that were selected as 'Primary' across the two rounds. V.Important = very important; M.Important = moderately important; S.Important = somewhat important; I = initial; S = sustained; V = visual; A = auditory; O/S = olfactory/somatosensory; D = declarative; R = reception; P = production; Expectancy = expectancy/reward prediction error; Action Selection = action selection/preference-based decision-making; Response Selection = response selection/inhibition reward valuation/salience and deficient action selection/ inhibitory control [13] ; (iii) the maladaptive habit-learning model, proposing a transition between goal-directed action selection and stimulus-response habits and compulsions [65] ; and (iv) decision-making models, focusing upon how reward prediction and affective valuation influence preference-based decisions [71, 72] . There are robust practical and theoretical reasons to incorporate the five neuropsychological constructs from the Positive Valence System, plus the response inhibition and compulsivity constructs, in future research and clinical programs. Large-scale addiction studies such as the US National Institutes of Health (NIH) ABCD study are already heading in this direction (see ABCDStudy.org). From a research perspective, our findings stimulate the development of new addiction models seeking to integrate these constructs in a unifying framework that accounts for disorder staging. By contrast, a widely used model for describing addictive behaviours-the 'dual systems' approach, referring to an imbalance between reward valuation and the cognitive control systems [73] -focuses upon only two of the Delphi-identified constructs. However, some experts support a broader and more nuanced view [74, 75] in which many related, yet distinct, constructs (i.e. reward valuation, reward learning, preference-based decisions, action selection, habits and corticostriatal neural systems) determine the expression of addictive behaviours. It is promising that the present consortium agrees with a high level of consensus on the essential constructs underpinning addictions.
Future research should delineate how these seven factors are independent or inter-related. From a clinical perspective, a first step towards knowledge implementation is developing an assessment tool that measures these constructs validly and reliably. Along these lines, Kwako and colleagues proposed an assessment battery to target three primary domains (incentive salience, negative emotionality and executive functions) [76] . The RDoC initiative is also contributing tasks towards research programmes whose goal is to collect data on dimensions relevant to mental health from a sample of 1 million or more individuals (https://allofus.nih.gov). Such large-scale data collection efforts will help greatly in clarifying constructs broadly relevant to addictive behaviours and the mechanisms and processes relevant to various stages of addiction. Looking ahead, we need to develop an assessment battery that is time-efficient, ecologically valid, psychometrically sound, sensitive to the seven primary domains identified herein, incorporates performance-and questionnaire-based measures and is well tolerated.
Relevance to staging of disorder
Our findings raise the important issue of how the primary constructs (i) contribute to vulnerability to, or maintenance of, addictive behaviour; and (ii) predate addiction and emerge as a consequence of repeated drug use in vulnerable individuals. In relation to the former, aspects of the Positive Valence System, and the associated attribution of incentive salience to reward-related stimuli, are considered important. For instance, at the vulnerability stage, reward valuation and linked anticipation may be a prominent factor in determining an individual's responsiveness to addiction-related cues. At later stages of the addiction cycle, an allostatic-incentive salience role of substance-or addiction-related cues is likely to be present, and therefore reward valuation remains relevant to both vulnerability to relapse and chronicity. In relation to vulnerability to relapse (or chronicity), all seven primary constructs were considered relevant drivers (see Figs 4 and 5), but only 'habit' and 'compulsivity' were argued to be selectively relevant to chronicity.
Pre-clinical data suggest that substance use may switch from being impulsive to compulsive over time, reflecting a shift from dopaminergic dysregulation of ventral to dorsal striatum function and related cortical, pallidal and thalamic circuitry [50, 77] . Despite recent evidence that activation of the habit system during cue-elicited tasks in humans is the best predictor of relapse [78] , habit and compulsivity are two constructs highlighted in this Delphi study receiving the least human research to date. For instance, there has been little research investigating whether habits represent a gateway for the development of compulsivity [16, 29] , and whether those with addictions show altered habit formation [79] , impaired ability Figure 4 Experts' endorsements for stages of disorder for primary constructs to disengage their habits in the face of negative consequences and, if so, whether habits can be updated and cognitive control retrained through intervention. Recent meta-analyses confirmed habit-related neuropsychological deficits in individuals with alcohol use disorder [80] and gambling disorder [81] compared to control participants. Beyond cue-elicited tasks that relate partly to compulsivity (but not designed originally to encompass it), laboratorybased models have been developed to assay habit learning, although these have yet to be applied widely to addictions (see [82] for a detailed review). Such experimental paradigms tend to be longer and more complex and may require approaches from growing fields such as computational psychiatry to optimize them for use in research and clinical settings. Validated clinical scales of compulsivity are also needed.
Relevance to treatment and prevention and potential barriers to progress
Evidently, the relevance of many neuropsychological constructs are not constrained by traditional diagnostic boundaries, forming (at least partially) shared dysfunctions at the core of many substance and behavioural addictions. Established approaches to the clinical assessment and management of individuals with addictive disorders have not benefited fully from these emerging insights, with neuroscientists typically more aligned to the laboratory than the clinic. The essential neuropsychological dimensions currently identified provide a framework to guide clinicians and researchers through a consensual, collaborative agenda. Consistent with the RDoC framework, this agenda involves examining the diagnostic and prognostic value of dimensional measures of the constructs identified here, and the design of targeted, transdiagnostic treatment approaches to address these vulnerabilities and dysfunctions. The identification of neuropsychological targets may facilitate alternative interventions to succeed where others have failed. For instance, in the case of habits and compulsions (i.e. constructs related to chronicity), activities that re-engage the cognitive control/goal-directed systems (including mindfulness meditation or goal management strategies) may be effective in treating addictive behaviours [83] . Regarding reward valuation, an individual who is vulnerable to placing a high value on addiction-related hedonic experiences (e.g. substance use) may be at risk of developing an addiction. However, the same reward value system may also be protective if one can apply (or be treated to apply) their high reward value system to new forms of adaptive learning towards less harmful and more functional rewards or to distant rewards placing one towards a non-use preference (see [84] for potential applications of this approach to contingency management, motivational interviewing/enhancement and targeted media campaigns). Such 'redirecting' approaches assume that the reward system is still fully operative and flexible, and thus malleable for 'domain-derived' interventions [84] . Accordingly, future research and clinical work can build upon the available neuroscience knowledge and be evidencebased. The consensus-derived knowledge from this paper thus provides a framework for grouping more homogeneous subtypes of addictions (currently classified in disparate categories), more validly linking disorder categories to molecular, cellular and neural dimensions, and guiding clinical interventions and treatments to core dimensions driving and maintaining addiction-related disorders. A key additional advantage is the potential for prevention, as aberrant functioning in these systems can be detected well before first use of a substance and/or engagement in a maladaptive behaviour.
In relation to staging of illness, this neuropsychological approach underscores the frequent finding that many relevant phenomena vary continuously within and between addictions and mental disorders more broadly and in the population at large. These neuropsychological dimensions (may/arguably) become pathological at the extremes of an otherwise normal distribution [41] . An online version of such an assessment battery could be used to measure and monitor potential risk factors for large cohort/population-based studies with an eye towards early intervention. Figure 5 Expert-endorsed primary constructs as a function of the major Research Domain Criteria (RDoC) domains (green = positive valence system; red = negative valance system; blue = cognitive system) and the constructs within these domains that are most relevant to the process of addiction (i.e. as a function of the relative size/width of the circles). Also illustrated are the relative influences of the seven primary constructs on the vulnerability to or the chronicity of addiction
Limitations
Experts were only included if they were fluent English speakers. A handful of experts disagreed fundamentally with the use of the RDoC, arguing that they are too biological and reductionist, making the translation to phenomenological and other applications difficult [85] . Indeed, many of the best currently available treatments are psychosocial in nature. Our findings need to be used to refine these approaches to create new psychosocial options that are more personalized and better targeted so as to improve current standards of assessment and care. Such views may have led experts to be less invested in the Delphi process, although the very high retention rate suggests otherwise. Other limitations relate to potential biases to our approach: (i) the research team promoting the Delphi have expressed publicly their views about addiction, which may have biased participants; (ii) although efforts were made to guarantee a broad representation of experts, the promoters may have introduced biases in the selection of experts; and (iii) finally, the pool of experts over-represented European locations (versus the Americas and other nonwestern countries) and academic positions (versus clinical practitioners), and thus results may be susceptible to biases related to prevailing views on addiction within Europe and academia.
CONCLUSIONS
The theoretical framework established in the current study provides a platform to test predictions that: (1) the majority of individuals with substance and behavioural addictions have specific dysfunctions in the primary constructs identified by our International Expert Consortium; (2) these dysfunctions cut across diagnostic boundaries (i.e. individuals from different addictions will cluster into the same neuropsychological phenotypes); and (3) these indices can be linked differentially to vulnerability and chronicity (i.e. stage of disorder). This framework may enable grouping of more homogeneous disorder subtypes, better linking of behavioural questionnaire phenotypes to neural, cellular and genetic dimensions, guiding clinical decisions to the core issues that drive addictions and measuring the success and failure of treatment (i.e. providing a clinical end-point). It is envisioned that the findings will guide and fast-track the development of a new generation of neuropsychological assessment tools, and improve the monitoring and effectiveness of both established and future novel interventions.
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